SharonAI Holdings, an Australian neocloud focused on high-performance computing and cloud GPU infrastructure, is navigating a critical shift from early commercialization toward large-scale deployment. The third quarter of 2026, ended September 30, 2026, provides an early window into whether the company can turn its expanding contract book into actual billing capacity. Investors continue to balance a roughly $9.6 billion contract pipeline against risks around data center construction and customer acceptance. With revenue still modest compared to the company's valuation, the focus remains on deployment progress and the realism of management's revenue ramp rather than any single quarter's headline figures. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
For the third quarter of 2026, SharonAI reported revenue of approximately $9.9 million, missing the analyst consensus of about $26.9 million. Revenue rose 1,859% year over year from $0.5 million in the third quarter of 2025 and increased 414% sequentially from the second quarter of 2026, highlighting how early-stage the business still is despite the rapid expansion.
On the bottom line, the company reported an adjusted net loss of $1.14 per share, which beat the consensus estimate of a $1.93 loss per share. Net loss widened to $43.8 million from $1.6 million a year earlier, while adjusted EBITDA was negative $25.8 million, compared with negative $1.1 million in the prior-year quarter. These figures reflect substantial ongoing investment in GPU procurement and data center buildout ahead of expected billing start dates.
SharonAI shares declined in after-hours trading following the report, as investors focused on the revenue miss even though the company beat adjusted earnings expectations. The stock has shown significant volatility in recent months amid broader caution around AI and neocloud names, plus company-specific concerns over execution. Sentiment ahead of the release was already mixed, with the large contract book and recent capital raises offset by questions about when revenue conversion would occur. The post-earnings reaction indicates the market remains most attuned to the speed at which contracted capacity begins generating recurring billing revenue.
The standout signal from the quarter is management's guidance that ARR should rise from roughly $50 million in September 2026 to between $400 million and $450 million by January 2027. That increase is linked to about 30 megawatts of the company's 129 MW of contracted capacity expected to begin billing from January 2027. SharonAI also noted 212 MW of total capacity planned across Australia and New Zealand in 2027, with around 155 MW available for sale into the GPU compute market.
Several factors will merit close attention in coming quarters. Customer acceptance milestones matter most right now; management expects tranche two of its global technology customer deployment and its ESDS contract to reach acceptance in December, with billing to follow. Financing access will also be key after more than $2.6 billion raised since December 2025, including a $356 million GPU-backed debt facility. Capital spending and cash burn deserve monitoring given the gap between contracted value and current revenue recognition. Finally, deployment timelines and the pace of new contract signings will determine whether the guided revenue ramp takes shape.
From what I see, tools like Tickeron’s AI Screener can help investors quickly filter for patterns and fundamentals across many names, which I find useful when tracking fast-moving stories like this one. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry. In my view, incorporating these resources into routine research adds another layer of perspective without replacing fundamental review.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where SHAZ advanced for three days, in 44 of 68 cases, the price rose further within the following month. The odds of a continued upward trend are 65%.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where SHAZ's RSI Oscillator exited the oversold zone, 5 of 9 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 56%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 16 of 39 cases where SHAZ's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 41%.
The Moving Average Convergence Divergence (MACD) for SHAZ just turned positive on October 29, 2026. Looking at past instances where SHAZ's MACD turned positive, the stock continued to rise in 15 of 44 cases over the following month. The odds of a continued upward trend are 34%.
The Momentum Indicator moved below the 0 level on November 10, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on SHAZ as a result. In 14 of 60 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 23%.
The 50-day moving average for SHAZ moved below the 200-day moving average on November 04, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where SHAZ declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 65%.
The Aroon Indicator for SHAZ entered a downward trend on November 16, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 8 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 83 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.691) is normal, around the industry mean (2.898). P/E Ratio (-1.614) is within average values for comparable stocks, (18.492). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.284). Dividend Yield (0.000) settles around the average of (0.224) among similar stocks. P/S Ratio (588.235) is also within normal values, averaging (139.965).
The Tickeron Price Growth Rating for this company is 92 (best 1 - 100 worst), indicating slightly worse than average price growth. SHAZ’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SHAZ’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry InformationTechnologyServices